Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Roche Diagnostics extends R&D collaboration agreement with molecular-diagnostics company
November 3rd, 2005
Epigenomics, AG, (ECX), a molecular-diagnostics company developing tests based on DNA methylation, announced an extension to its existing agreement with Roche Diagnostics. The R&D part of the collaboration, which covers the development of five cancer diagnostic tests, has been extended for a minimum of 6 months, with the option to prolong and potentially expand for another 18 months. Financial terms were not disclosed. "Shortly before announcing final validation data for our two lead products, we extended our R&D partnership. This gives both parties the flexibility to act based upon the final outcomes of these programs. I expect further newsflow from...
Source: Women's Health Weekly (2005-11-03)
|
